Question to the Department for Business and Trade:

To ask the Secretary of State for Business and Trade, with reference to the US Trade Representative's press release entitled U.S. Government Announces Agreement in Principle with the United Kingdom on Pharmaceutical Pricing, published on 1 December 2025, what the other commitments referred to are.

As set out by the Secretary of State in his written statement to Parliament on 2 December, we have secured a zero percent tariff on all pharmaceuticals exported to the US - the lowest rate offered to any country. The UK has also secured preferential terms for the UK’s medical technology exports for three years, meaning no additional new tariffs on medical technologies.

This agreement was supported by the government’s commitment to investing 25% more in new innovative medicines – the first major increase in over two decades – which will support improved access to new medicines for NHS patients.